Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Topical retinoids effectively improve photodamaged skin.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Alopecia areata patients have higher oxidative stress and lower antioxidant levels.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Combined minoxidil and tretinoin solution works as well as regular minoxidil for male hair loss.

Eruptive vellus hair cysts are a cosmetic skin condition, more common in young adults, with few effective treatments.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

AKN might be a skin marker for metabolic syndrome.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Cetuximab can cause eyelash growth, which is rare but manageable.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.